Home NDC 43598-684 Eslicarbazepine Acetate
Product NDC 43598-684
11-digit product format 435980684
Labeler code 43598
Product ID 43598-684_75484338-6d78-877c-086f-61467c8dd5e4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Eslicarbazepine Acetate
Dosage form TABLET
Route ORAL
Labeler Dr.Reddys Laboratories Inc
Application ANDA211238
Marketing category ANDA
Marketing start 2025-05-06
Substance ESLICARBAZEPINE ACETATE
Active strength 200 mg/1
Pharmacologic classes Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A211238-001 ESLICARBAZEPINE ACETATE ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 A211238-002 ESLICARBAZEPINE ACETATE ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 A211238-003 ESLICARBAZEPINE ACETATE ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 A211238-004 ESLICARBAZEPINE ACETATE ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 132 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A211238-001 ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB 2021-06-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A211238-002 ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB 2021-06-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A211238-003 ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB 2021-06-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A211238-004 ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB 2021-06-29 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 132 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Eslicarbazepine Acetate
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ESLICARBAZEPINE ACETATE 200 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination BEA68ZVB2K Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1482507 Internal RxNorm lookup 1482515 Internal RxNorm lookup 1482521 Internal RxNorm lookup 1482525 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 43598-684-30 Eslicarbazepine Acetate 30 in 1 BOTTLE TABLET 30 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 43598-684 ESLICARBAZEPINE ACETATE TABLET [DR.REDDYS LABORATORIES INC] 4 Current NDC, 1 package rows 20250507_190fccbc-da3f-b175-ac02-f2c4307a15c3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 43598-684-30 43598068430 30 TABLET in 1 BOTTLE (43598-684-30) 30 tablet 2025-05-06 No No Current